Clinical trial
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
NCT01617161
Study timeline
Study start (actual)2012-07-25Date precision: day
Registry last updated2026-09-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
Proton Beam TherapyRADIATION
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
University of Pennsylvaniacollaborator
National Cancer Institute (NCI)collaborator
Northwestern Medicine Chicago Proton Centercollaborator
ProCure Proton Therapy Centercollaborator
Washington University School of Medicinecollaborator
University of Washingtoncollaborator
Rutgers Cancer Institute of New Jerseycollaborator
Mayo Cliniccollaborator
University of Maryland, Baltimorecollaborator
University Hospitals Cleveland Medical Centercollaborator
University of Floridacollaborator
Provision Center for Proton Therapycollaborator
Mapped research locations
BostonMassachusetts, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1St LouisMissouri, United States1SeattleWashington, United States1ClevelandOhio, United States1JacksonvilleFlorida, United States1RochesterMinnesota, United States1KnoxvilleTennessee, United States1New BrunswickNew Jersey, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01617161 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.